Evidence for increased D2 receptor density in TRS is mixed and may vary by brain region, potentially limiting the effectiveness of conventional D2 antagonists
There is no single published list of FDA-approved peptides, but the category of formally approved peptide-based drugs includes GLP-1 receptor agonists (Ozempic, Wegovy, Mounjaro, Zepbound), insulin analogues, leuprolide, vasopressin analogues, oxytocin, and several others used in endocrinology and oncology
Specialized toxicology research shows no embryo-fetal developmental toxicity, no genetic mutagenicity in bacterial and mammalian cell assays, and no adverse reproductive effects in animal models
Gogas, H., et al., Biomarkers in melanoma
While not strictly required, Vitamin C acts as a major catalyst for both
Let's separate the noise from the science